Acurex Biosciences Corporation
Acurex Biosciences Corporation, located in San Carlos, CA, is dedicated to advancing drug development for neurodegenerative diseases, particularly Parkinson's disease. The company leverages a proprietary platform based on a breakthrough discovery from Stanford University, focusing on identifying druggable targets that can alter disease progression rather than merely treating symptoms.
Acurex's lead drug candidate, CU13001, is an oral, brain-penetrant small molecule designed to utilize their innovative approach to treating Parkinson's disease. This therapy is part of a broader pipeline of early-stage neurology drug candidates aimed at achieving significant biomarker changes in neurological diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.